[HTML][HTML] Yersinia pestis and plague: an updated view on evolution, virulence determinants, immune subversion, vaccination, and diagnostics
CE Demeure, O Dussurget, G Mas Fiol… - Genes & …, 2019 - nature.com
Plague is a vector-borne disease caused by Yersinia pestis. Transmitted by fleas from
rodent reservoirs, Y. pestis emerged< 6000 years ago from an enteric bacterial ancestor …
rodent reservoirs, Y. pestis emerged< 6000 years ago from an enteric bacterial ancestor …
Protein delivery into eukaryotic cells by type III secretion machines
JE Galán, H Wolf-Watz - Nature, 2006 - nature.com
Bacteria that have sustained long-standing close associations with eukaryotic hosts have
evolved specific adaptations to survive and replicate in this environment. Perhaps one of the …
evolved specific adaptations to survive and replicate in this environment. Perhaps one of the …
Inflammatory blockade restores adult hippocampal neurogenesis
Cranial radiation therapy causes a progressive decline in cognitive function that is linked to
impaired neurogenesis. Chronic inflammation accompanies radiation injury, suggesting that …
impaired neurogenesis. Chronic inflammation accompanies radiation injury, suggesting that …
[HTML][HTML] The NLRP12 inflammasome recognizes Yersinia pestis
Yersinia pestis, the causative agent of plague, is able to suppress production of
inflammatory cytokines IL-18 and IL-1β, which are generated through caspase-1-activating …
inflammatory cytokines IL-18 and IL-1β, which are generated through caspase-1-activating …
Type III secretion system effector proteins: double agents in bacterial disease and plant defense
JR Alfano, A Collmer - Annu. Rev. Phytopathol., 2004 - annualreviews.org
▪ Abstract Many phytopathogenic bacteria inject virulence effector proteins into plant cells via
a Hrp type III secretion system (TTSS). Without the TTSS, these pathogens cannot defeat …
a Hrp type III secretion system (TTSS). Without the TTSS, these pathogens cannot defeat …
[HTML][HTML] Maintaining integrity under stress: envelope stress response regulation of pathogenesis in gram-negative bacteria
The Gram-negative bacterial envelope is an essential interface between the intracellular
and harsh extracellular environment. Envelope stress responses (ESRs) are crucial to the …
and harsh extracellular environment. Envelope stress responses (ESRs) are crucial to the …
War and peace at mucosal surfaces
PJ Sansonetti - Nature Reviews Immunology, 2004 - nature.com
That we live with numerous bacteria in our gut without any adverse effects is a remarkable
feat by the body's immune system, particularly considering the wealth of sensing and effector …
feat by the body's immune system, particularly considering the wealth of sensing and effector …
Insights into the evolution of Yersinia pestis through whole-genome comparison with Yersinia pseudotuberculosis
PSG Chain, E Carniel, FW Larimer… - Proceedings of the …, 2004 - National Acad Sciences
Yersinia pestis, the causative agent of plague, is a highly uniform clone that diverged
recently from the enteric pathogen Yersinia pseudotuberculosis. Despite their close genetic …
recently from the enteric pathogen Yersinia pseudotuberculosis. Despite their close genetic …
[HTML][HTML] Structural modifications of bacterial lipopolysaccharide that facilitate gram-negative bacteria evasion of host innate immunity
M Matsuura - Frontiers in immunology, 2013 - frontiersin.org
Bacterial lipopolysaccharide (LPS), a cell wall component characteristic of Gram-negative
bacteria, is a representative pathogen-associated molecular pattern that allows mammalian …
bacteria, is a representative pathogen-associated molecular pattern that allows mammalian …
[HTML][HTML] Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response
SW Montminy, N Khan, S McGrath, MJ Walkowicz… - Nature …, 2006 - nature.com
At mammalian body temperature, the plague bacillus Yersinia pestis synthesizes
lipopolysaccharide (LPS)–lipid A with poor Toll-like receptor 4 (TLR4)–stimulating activity …
lipopolysaccharide (LPS)–lipid A with poor Toll-like receptor 4 (TLR4)–stimulating activity …